Resumen de Investigación
Analyzed using Evidence Intelligence™

Closed-loop insulin delivery reduces hypoglycemia postpartum

Última actualización 22 de agosto de 2026

Key finding

Participants randomized to closed-loop insulin delivery spent less time <70 mg/dL (1.7 ± 0.8% vs. 5.5 ± 3.3%; P < 0.001).

The study investigated the effects of closed-loop insulin delivery on hypoglycemia in women with Type 1 diabetes postpartum, finding reduced hypoglycemia with this method.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Guarda investigacion, organiza estudios y vuelve a encontrar evidencia importante rapidamente.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

The study investigated the effects of closed-loop insulin delivery on hypoglycemia in women with Type 1 diabetes postpartum, finding reduced hypoglycemia with this method.

Clinical relevance

Managing blood sugar levels is crucial for women with Type 1 diabetes, especially postpartum. The findings suggest that closed-loop insulin delivery systems can significantly reduce the risk of hypoglycemia, which can lead to severe complications. This could inform treatment choices and improve quality of life for postpartum women with diabetes.

Keep in mind

Limited generalizability due to specific population characteristics. Short duration of follow-up may not capture long-term effects. Potential for unmeasured confounders affecting results.

Published in

Referencia de la Revista

Publication details and source links for this paper.

Lois ED, Denice SF, Patricia L, et al. Women with Type 1 Diabetes Randomized to Closed-Loop Insulin Delivery Postpartum Had Less Hypoglycemia. Diabetes Care. 2023;46(12):2258-2266. doi:10.2337/dc23-0882

Efectos Principales

Participants using closed-loop insulin delivery spent less time <70 mg/dL (1.7% vs. 5.5%; P < 0.001).

Those using closed-loop delivery had less time <54 mg/dL (0.3% vs. 1.1%; P = 0.008).

No episodes of diabetic ketoacidosis were reported in either group.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Hybrid closed-loop system, Insulin pump and Diabetic ketoacidosis, Percentage of time spent above 180 mg/dL, Percentage of time spent below 70 mg/dL, and 3 more.

Primary intervention

Hybrid closed-loop system

Primary outcomes

  • Diabetic ketoacidosis
  • Percentage of time spent above 180 mg/dL
  • Percentage of time spent below 70 mg/dL

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

7
Evidence pairs
7
Relationships
3
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

3

Related topics

7

Evidence pairs

575

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 7 evidence relationships
  • Includes primary outcome data
  • Linked to 3 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Agrega evidencia relacionada a tu Evidence Tracker

Guarda estudios y paginas de evidencia, organiza tu Evidence Tracker y manten en un solo lugar la investigacion que te importa.

Evidencia principal

Relación de evidencia

Insulin Delivery Systems and CGM Time in Range

Evidencia relacionada

Relación de evidencia

Insulin Delivery Systems and Hypoglycemia

Guardar evidencia

Tema de evidencia

Diabetes Technology

Guardar evidencia

Core evidence

Study findings

The primary outcomes reported in this study.

Diabetic ketoacidosis

Hybrid closed-loop system → Diabetic ketoacidosis

Hybrid closed-loop system → Diabetic ketoacidosis

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 3 studies
ImpactScore™
50
Neutral
ConsistencyScore™
100
consistent
Estudios de apoyo: Basado en 3 estudios
Add to Evidence Tracker

Percentage of time spent above 180 mg/dL

Hybrid closed-loop system → Percentage of time spent above 180 mg/dL

Hybrid closed-loop system → Percentage of time spent above 180 mg/dL

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Percentage of time spent below 70 mg/dL

Hybrid closed-loop system → Percentage of time spent below 70 mg/dL

Hybrid closed-loop system → Percentage of time spent below 70 mg/dL

Evidence Intelligence™
EvidenceScore™
Moderate
Score 69 · Based on 2 studies
ImpactScore™
100
Very Positive
ConsistencyScore™
100
consistent
Estudios de apoyo: Basado en 2 estudios
Add to Evidence Tracker

Severe hypoglycemia

Hybrid closed-loop system → Severe hypoglycemia

Hybrid closed-loop system → Severe hypoglycemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Time in range

Hybrid closed-loop system → Time in range

Hybrid closed-loop system → Time in range

Evidence Intelligence™
EvidenceScore™
86
Strong
ImpactScore™
79
Positive
ConsistencyScore™
70
generally_consistent
Estudios de apoyo: Basado en 12 estudios
Add to Evidence Tracker

Time spent below 54 mg/dL

Hybrid closed-loop system → Time spent below 54 mg/dL

Hybrid closed-loop system → Time spent below 54 mg/dL

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Percentage of time spent below 70 mg/dL

Insulin pump → Percentage of time spent below 70 mg/dL

Insulin pump → Percentage of time spent below 70 mg/dL

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Estudios de apoyo: Basado en 1 estudio
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

La Evidencia Sugiere

  • Closed-loop insulin delivery reduced time <70 mg/dL by 3.8%.
  • Time <54 mg/dL decreased by 0.8% with closed-loop delivery.
  • No severe hypoglycemia episodes were reported in either group.
who this applies

A quién se aplica

  • Women with Type 1 diabetes postpartum.
  • Participants who are managing diabetes with insulin therapy.
keep in mind

Tener en Cuenta

  • Results may not apply to all women with diabetes.
  • Study focused on a specific insulin delivery system.
  • Further research is needed to confirm long-term benefits.
between the lines

Entre Líneas

  • Limited generalizability due to specific population characteristics.
  • Short duration of follow-up may not capture long-term effects.
  • Potential for unmeasured confounders affecting results.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Delivery Systems and CGM Time in Range, Insulin Delivery Systems and Diabetic ketoacidosis.

Relaciones de evidencia relacionadas

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Insulin Delivery Systems improve cgm time in range?

Strong Evidence

Insulin Delivery Systems may improve CGM Time in Range.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Time in range

    EvidenceScore™ Strong | EvidenceScore™ 86.0 | moderate positive | ConsistencyScore™ Generally Consistent | 1 study

Why this answer: This answer is based on 20 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
20 supporting studiesUpdated: Aug 2026

Does Insulin Delivery Systems affect hypoglycemia?

Strong Evidence

Insulin Delivery Systems may improve Hypoglycemia.

ConsistencyScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    Severe hypoglycemia

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Population details are unavailable.
8 supporting studiesUpdated: Aug 2026

Does Hybrid closed-loop system improve diabetic ketoacidosis?

Strong Evidence

Current evidence does not show a clear benefit of Hybrid closed-loop system for Diabetic ketoacidosis.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Diabetic ketoacidosis

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | neutral | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Hybrid closed-loop system improve percentage of time spent below 70 mg/dl?

Moderate Evidence

Hybrid closed-loop system appears to improve Percentage of time spent below 70 mg/dL.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Percentage of time spent below 70 mg/dL

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

Sin anuncios. Sin rastreo.

Centrada en la evidencia, no en la publicidad.

Segura y privada

Tus datos siempre están protegidos.

Siempre al día

Se agregan nuevos estudios todos los días.